Neuro-Oncology News

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, highlights keynote addresses from International Symposium on Pediatric Neuro-Oncology.

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, highlights the important takeaways from International Symposium on Pediatric Neuro-Oncology.

PHILADELPHIA — In this video, Michael Fisher, MD, discusses the results of a natural history study he presented at the International Symposium on Pediatric Neuro-Oncology.

PHILADELPHIA — In this video, Michael Fisher, MD, discusses the results of the SJMB12 (NCT01878617) trial.

It’s only the beginning.

PHILADELPHIA — In this video, Michael Fisher, MD, highlights a keynote presentation given by Charles Limoli, PhD, at the International Symposium on Pediatric Neuro-Oncology.

PHILADELPHIA — In this video, Michael Fisher, MD, highlights the sessions and presentations at the International Symposium on Pediatric Neuro-Oncology.

Individuals with therapy-refractory cancer who received waivers to participate in a clinical trial for off-label targeted therapies achieved similar clinical benefits as those who took part in the study without an exception.

CHICAGO — Time between therapy regimens can safely be offered to certain children with cancer to promote quality of life and explore goals of care without negatively affecting survival, according to data presented at ASCO Annual Meeting.

The FDA granted accelerated approval to repotrectinib for the treatment of adults and children 12 years and older with solid tumors that have a neurotrophic tyrosine receptor kinase gene fusion.